Related Experiment Video

Updated: May 16, 2026

Studying Chronic Exposure of Mice to Ultraviolet B Radiation
03:20

Studying Chronic Exposure of Mice to Ultraviolet B Radiation

Published on: August 19, 2025

Review of current clinical studies of vitiligo treatments

Igor V Korobko1

  • 1VR Foundation, New York, New York, USA. i.korobko@vrfoundation.org

Dermatologic Therapy
|December 15, 2012
PubMed

Insights

Vitiligo treatment options are limited, often failing to respond. Recent clinical studies focus on novel therapies and predictors to improve vitiligo management outcomes.

Area of Science:

  • Dermatology
  • Clinical Research

Background:

  • Vitiligo presents limited treatment options, with frequent refractoriness to existing therapies.
  • There is a critical need for novel treatments and improved management strategies for vitiligo.

Purpose of the Study:

  • To review recent clinical studies (since 2009) on vitiligo treatment.
  • To evaluate the safety and efficiency of novel and improved existing vitiligo treatments.
  • To identify predictors of treatment efficiency in vitiligo.

Main Methods:

  • Overview of recent clinical studies published since 2009.
  • Analysis of studies evaluating novel treatment safety and efficacy.
  • Identification of factors predicting treatment response in vitiligo.

Main Results:

  • Recent studies explore novel therapeutic approaches for vitiligo.
  • Improvements in existing vitiligo treatments are being investigated.
  • Predictors for treatment efficiency are being defined and evaluated.

Conclusions:

  • Ongoing research aims to enhance vitiligo management through new treatments.
  • Identifying predictors can optimize treatment selection and application for better vitiligo outcomes.
  • Further clinical studies are essential for advancing vitiligo care.

Related Concept Videos

Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Acne Infection01:27

Acne Infection

Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...